People: T. Rowe Price Group Inc (TROW.OQ)

TROW.OQ on NASDAQ Stock Exchange Global Select Market

28 Jul 2014
Price Change (% chg)

$-0.04 (-0.05%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Sommer, Alfred 

Brief Biography

Dr. Alfred Sommer, M.D., is Independent Director of T. Rowe Price Group, Inc. He serves as lead independent director, chairman of the Nominating and Corporate Governance Committee, and as a member of the Executive Committee and Executive Compensation Committee. Dr. Sommer designed and led major research programs around the world, and in 1980, returned to The Johns Hopkins University where he founded the Dana Center for Preventive Ophthalmology. From 1990 to 2005, Dr. Sommer served as the Dean of The Johns Hopkins Bloomberg School of Public Health. He remains Professor of International Health and Epidemiology, Dean Emeritus of the School of Public Health, and Professor of Ophthalmology in the School of Medicine. Dr. Sommer served for a decade on the executive committee of the board of the Academy for Educational Development (AED). He also served as president of the Association of Schools of Public Health and chaired its audit committee. Since 2008, he has served on the board of the Lasker Foundation. He was chair of the Micronutrient Forum for nearly 20 years and is the senior medical advisor for Helen Keller International. Dr. Sommer is a graduate of Union College, received his M.D. from Harvard Medical School, and his Master of Health Science degree in Epidemiology from The Johns Hopkins University. He is an elected member of both the National Academy of Sciences and the Institute of Medicine. Dr. Sommer has been a member of the board of Becton Dickinson & Company, a medical technology company, since 1998, where he has served on the audit committee and executive committee, chaired the science and innovation committee, and chairs the nominating and governance committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Brian Rogers


James Kennedy


Edward Bernard


Kenneth Moreland


Jessica Hiebler


Christopher Alderson

As Of 30 Dec 2013
Search Stocks